Adenosine Receptors and Tumor Antiangiogenesis

Olah, Mark E.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: Research Project (R01)
• Project #: 5R01CA079531-03
• Application #: 6150348
• Study Section: Experimental Therapeutics Subcommittee 1 (ET)
• Program Officer: Mohla, Suresh
• Project Start: 1999-04-09
• Project End: 2004-01-31
• Budget Start: 2000-05-10
• Budget End: 2001-01-31
• Support Year: 3
• Fiscal Year: 2000
• Total Cost: $178,107

Institution

• Name: University of Cincinnati
• Department: Pharmacology
• Type: Schools of Medicine
• City: Cincinnati
• State: OH
• Country: United States
• Zip Code: 45221

Publications

Fang, Ying; Olah, Mark E (2007) Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J Pharmacol Exp Ther 322:1189-200

Gardner, Alicia M; Olah, Mark E (2003) Distinct protein kinase C isoforms mediate regulation of vascular endothelial growth factor expression by A2A adenosine receptor activation and phorbol esters in pheochromocytoma PC12 cells. J Biol Chem 278:15421-8

Olah, M E; Roudabush, F L (2000) Down-regulation of vascular endothelial growth factor expression after A(2A) adenosine receptor activation in PC12 pheochromocytoma cells. J Pharmacol Exp Ther 293:779-87